ProfileGDS5678 / 1427572_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 12% 12% 12% 10% 11% 13% 11% 11% 11% 12% 11% 11% 12% 14% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.3169412
GSM967853U87-EV human glioblastoma xenograft - Control 22.285812
GSM967854U87-EV human glioblastoma xenograft - Control 32.2891212
GSM967855U87-EV human glioblastoma xenograft - Control 42.2093610
GSM967856U87-EV human glioblastoma xenograft - Control 52.2320411
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.3717813
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.3072311
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.2655611
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.2499811
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.2758912
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.2732611
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.2588611
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.282312
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.3306814